RegMed is the fusion of innovation and high-tech with medicine. Regenerative medicine for everyone!
Our Story
2022
Idea: Regenerative medicine using stem cells should be universally accessible to all humans and animals. A treatment method characterized by simplicity and universal availability.
2023
Start of product development & first prototypes
Global PCT patent application for long-term protection of the idea
2024
Foundation of RegMed
Focus on promoting horse health
Establishment of unique production facility with 3D printer for highly complex filter systems in a clean room
2025
First treatments at a well-known equine clinic
Product launch at the end of 2025
2026+
Vision: Regenerative medicine for all and the evolution of veterinary and human medicine
Who is RegMed?
Tom Smets
Chief Executive Officer
Prof. Dr. Ing. Heiner Smets
Chief Technology Officer
Professor of Management & Technology
Cedric Smets
Chief Medical Officer
Orthopedist & Trauma Surgeon
Our Vision
Our vision is to make regenerative medicine available to everyone and every animal around the world by 2030. We want to bring medical care for humans and animals into the 21st century.
Tom Smets
CEO
“With RegMed, we make regenerative therapies available where they are needed – for humans and animals.”